Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Savior LifetecROCO:4167 67 5-Year Yield-on-Cost % is 4.36 as of Aug. 13, 2026, which is 627% above its 10-year median of 0.60. GuruFocus rates ROCO:4167 with a GF Score™ of 67/100 and a GF Value™ of NT$18.48 (Fairly Valued). The stock has 5 warning signs investors should review. Among 150 Biotechnology companies, Savior Lifetec ranks better than 74.67% on this metric.
Savior Lifetec's yield on cost for the quarter that ended in Mar. 2026 was 4.36.
The historical rank and industry rank for Savior Lifetec's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:4167'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.39 Med: 0.6 Max: 4.36
Current: 4.36
During the past 13 years, Savior Lifetec's highest Yield on Cost was 4.36. The lowest was 0.39. And the median was 0.60.
ROCO:4167's 5-Year Yield-on-Cost % is ranked better than 74.67% of 150
companies
in the Biotechnology industry
Industry Median: 1.595
vs ROCO:4167: 4.36
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Savior Lifetec 5-Year Yield-on-Cost % Related Terms
ROCO:4167 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Savior Lifetec's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Savior Lifetec 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Savior Lifetec's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Savior Lifetec's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Savior Lifetec is calculated as
Savior Lifetec (ROCO:4167) has a 5-Year Yield-on-Cost % of 4.36 as of Aug. 13, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Savior Lifetec and its competitors. This is 627% above median its historical median of 0.60. Over the past decade, Savior Lifetec's 5-Year Yield-on-Cost % has ranged from 0.39 to 4.36. According to the industry distribution chart, Savior Lifetec ranks #38 out of 150 companies in the Biotechnology industry, placing it in the top 25.3%.
Is Savior Lifetec's 5-Year Yield-on-Cost % too high?
Savior Lifetec's current 5-Year Yield-on-Cost % of 4.36 is 627% above median its 10-year median of 0.60. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 4.36. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.60. Savior Lifetec's value of 4.36 is 173.4% above this industry median. Based on the distribution chart, Savior Lifetec ranks #38 out of 150 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Savior Lifetec has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Savior Lifetec's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Savior Lifetec ranks #38 out of 150 companies for 5-Year Yield-on-Cost %. This puts Savior Lifetec in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 1.60. Savior Lifetec's value of 4.36 is 173.4% above this benchmark. Historically, Savior Lifetec's own 5-Year Yield-on-Cost % has ranged from 0.39 to 4.36 over the past decade. While the company's 10-year median is 0.60 vs. the industry median of 1.60, Savior Lifetec has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.60, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Savior Lifetec's current 5-Year Yield-on-Cost % of 4.36 is 173.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Savior Lifetec and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Savior Lifetec's current 5-Year Yield-on-Cost % is 4.36, which is 627% above median its own 10-year median of 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savior Lifetec stock overvalued right now?
Based on GuruFocus' analysis, Savior Lifetec (ROCO:4167) is currently considered Fairly Valued. The stock's GF Value™ is NT$18.48, compared to a current price of NT$18.45 — trading 0.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 4.36, which is 627% above median its 10-year median of 0.60 and 173.4% above the Biotechnology industry median of 1.60. Savior Lifetec's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Savior Lifetec (ROCO:4167), the current 5-Year Yield-on-Cost % is 4.36 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Savior Lifetec (ROCO:4167) Overvalued in 2026?
Based on GuruFocus' analysis, Savior Lifetec stock appears to be undervalued.
The current stock price of NT$18.45 is trading 0.2% below its estimated GF Value™ of NT$18.48.
GuruFocus considers Savior Lifetec to be Fairly Valued.
Key valuation signals for ROCO:4167:
5-Year Yield-on-Cost %: 4.36 (627% above median its 10-year median of 0.60)
GF Value™: NT$18.48 vs. price of NT$18.45 (0.2% below fair value)
Industry Position: 173.4% above the Biotechnology median (#38 of 150)
No single metric tells the full story. See the ROCO:4167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions: the Americas, Asia, Taiwan, and Europe.
67GF Score
Get the complete analysis for ROCO:4167
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4167 has been successfully added to your 
